CLINICAL_TRIALS
trial_result
· 2019-06-06
Clinical Trial Update: STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma [Phase 2]
Summary
Phase 2 trial update for vismodegib in locally advanced or metastatic basal cell carcinoma completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Basal Cell Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2019-06-06